Firefly Neuroscience Overview
Firefly Neuroscience (AIFF) has a ROE of -106.09%, below the sector sector average of -4.47%.
Get informed when a big investor buys or sells
+ Follow-106.09%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Firefly Neuroscience (AIFF) currently reports a ROE of -106.09%. That is below the sector sector average of -4.47%. Use the charts on this page to explore Firefly Neuroscience's ROE history and peer comparisons.
Firefly Neuroscience's ROE of -106.09% is lower than the its sector sector average of -4.47%. That is roughly 2274.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Firefly Neuroscience's current -106.09% should be judged against industry norms (sector average: -4.47%) and against AIFF's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of -106.09%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -4.47%. From there, open related valuation or income-statement pages for Firefly Neuroscience, and consider following AIFF for alerts when major investors trade the stock.
